Aflibercept-impurities | Pharmaffiliates

Aflibercept

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. Reference standards of Aflibercept API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Aflibercept - API Standards
    [catalogue_number] => PA PEP 001167
    [category_ids] => ,114,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 862111-32-8
    [pslug] => 862111-32-8-aflibercept-api-standards-papep001167
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA PEP 001167

Aflibercept - API Standards


  • Catalogue No.:PA PEP 001167

  • CAS :

    862111-32-8

  • Molecular Formula : NA

  • Molecular Weight : NA